Clene 10% holder sells 19,497 shares

Clene Inc. ten percent owner associated entity SymBiosis II, LLC sold 19,497 shares of Common Stock in open-market transactions.

Accepted by SEC EDGAR 04/30/2026 - 05:54 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Clene Inc. ten percent owner associated entity SymBiosis II, LLC sold 19,497 shares of Common Stock in open-market transactions. The sales occurred over three days at prices of $5.63, $5.90, and $6.08 per share. After these indirect sales, 277,569 shares of Clene Common Stock remain held through SymBiosis II, LLC.

Insider Trade Summary

Net Seller: 19,497 shares

Net Sell 3 txns

Insider Ugwumba Chidozie

Role 10% Owner

Sold 19,497 shs ($113K)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,736	$6.08	$35K
Sale	Common Stock	12,170	$5.63	$69K
Sale	Common Stock	1,591	$5.90	$9K

Holdings After Transaction: Common Stock — 277,569 shares (Indirect, By SymBiosis II, LLC)

Key Figures

Total shares sold: 19,497 shares Shares sold on Apr 30, 2026: 5,736 shares at $6.08/share Shares sold on Apr 29, 2026: 12,170 shares at $5.63/share +2 more

5 metrics

Total shares sold 19,497 shares Aggregate open-market sales reported in this Form 4

Shares sold on Apr 30, 2026 5,736 shares at $6.08/share Open-market sale of Common Stock

Shares sold on Apr 29, 2026 12,170 shares at $5.63/share Open-market sale of Common Stock

Shares sold on Apr 28, 2026 1,591 shares at $5.90/share Open-market sale of Common Stock

Shares held after transactions 277,569 shares Indirectly owned through SymBiosis II, LLC after last sale

Key Terms

open-market sale, ten percent owner, indirect ownership, Common Stock, +1 more

5 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

ten percent owner regulatory

""is_ten_percent_owner": 1"

indirect ownership financial

""ownership_type": "indirect""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Clene Inc. (CLNN) report in this Form 4?

Clene Inc. reported that a ten percent owner, through SymBiosis II, LLC, completed three open-market sales of Common Stock totaling 19,497 shares. These trades occurred on consecutive days and reflect indirect ownership changes rather than direct personal trades.

How many Clene (CLNN) shares were sold and at what prices?

The associated entity sold 19,497 shares of Clene Common Stock. Sales were executed at $5.63, $5.90, and $6.08 per share on different days, reflecting typical open-market pricing rather than a single block transaction.

What are the remaining Clene (CLNN) holdings after these insider sales?

Following the reported transactions, SymBiosis II, LLC continues to hold 277,569 shares of Clene Common Stock indirectly for the reporting person. This figure comes directly from the Form 4 and shows the post-transaction equity position still retained.

Over what dates did the Clene (CLNN) insider sales occur?

The reported indirect open-market sales took place on April 28, 2026, April 29, 2026, and April 30, 2026. Each day’s transaction is listed separately with its own share count, price, and updated share balance following the sale.

Were the Clene (CLNN) insider transactions direct or indirect holdings?

All reported transactions involved indirect ownership, identified in the filing as shares held "By SymBiosis II, LLC." The Form 4 classifies ownership type as indirect, meaning the entity, rather than the individual, is the direct share owner.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ugwumba Chidozie

(Last) (First) (Middle)

609 SW 8TH STREET

SUITE 510

(Street)

BENTONVILLE ARKANSAS 72712

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/28/2026		S		1,591	D	$5.9	295,475	I	By SymBiosis II, LLC
Common Stock	04/29/2026		S		12,170	D	$5.63	283,305	I	By SymBiosis II, LLC
Common Stock	04/30/2026		S		5,736	D	$6.08	277,569	I	By SymBiosis II, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Chidozie Ugwumba	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)